Skip to content

Apotheek Geusens

Active
Private limited companyfounded 200817 years activeDorpsstraat 61, 3900 Pelt, BelgiumKBO/BCE: BE 0808.370.977
Summary

Apotheek Geusens has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €215,168 and a net result of €89,629. Equity is shrinking by ~6.8% per year across the filed fiscal years. Its solvency ranks better than 66% of 12,411 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€404,835total assets 2025
Staff
3.2 FTE
Equity
€215,168
Profit
€89,629
Turnover not published (abridged schema)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
JUNIPER EBM · 100%
  • JUNIPER EBMDirector · permanent representative GEUSENS Eefje
Accounts 66 days early1 of 4 deeds read
Why 95- Sector Retail trade (NACE 47)+ Liquidity: current ratio 2.06, cash €149,598+ Founded in 2008+ Equity €215,168 (53.1% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 67% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 78-1
equity 53.1% of total assets
Liquidity 73-5
short-term debt 46.9% · cash 37.0%
Profitability 96-1
return on assets 22.1%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,169 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024lowest value 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026highest value
Credit up to €20,000 at 30 days acceptable
Liquidity ample (current ratio 2.06 against 2.07 in 2024; short-term debt: 46.9% and cash: 37% of total assets), and 46.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 67% on solvency, 79% on liquidity, 90% on profitability and 31% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 2.06, cash €149,598
NBB · annual accounts
lowers risk · Founded in 2008
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Equity €215,168 (53.1% of total assets)
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 26-11-2025, 66 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
66 days early
2024
39 days early
2023
58 days early
2022
69 days early
2021
54 days early
2020
45 days early
2019
46 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 54 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 4 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close07-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Resignation: GEUSENS Eefje (director)Appointment: JUNIPER EBM BV (director)…
  2. Annual accounts filedfiscal year 2025 · abbreviated…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: Board changedlatest change 30-12-2025 · 1 in office 1 joined · 1 left View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by JUNIPER EBM 100% View
  • Positive: 7 profitable years in a rowprofit 2025: €89,629 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€404,835
Profit
€89,629
Solvency
53.1%
Total assets▼ 2.4%
Net result
20192025
Go to Financials

Timeline

Events
13
Since
2016
Next accounts
by 31-01-2027
  1. 04-12-2023Annual accounts filed
  2. 23-11-2022Annual accounts filed
  3. 30-06-2022Highest result since 2019
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
11-12-2008
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.